STEERING COMMITTEE OF MEDICADEMY PHARMACOVIGILANCE

The Steering Commitee of Medicademy Pharmacovigilance comprises members from the industry,
the authorities and universities. The Steering Commitee is responsible for the professional framework of the programme and the continuous development of the individual modules, including scope, contents, level
and uniformity.

As of February 15, 2013, the Steering Commitee is composed by the following members:

DORIS STENVER,
MD, MPA, Chief Medical Officer, EU Pharmacovigilance Working Party Delegate, Danish Health and Medicines Authority

EA DIGE,
EU-Qualified Person for Pharmacovigilance, Director, ALK Abelló A/S

ELLEN RAVN ENGLEV,
MSc Pharm, Director, Case Management I, Safety Operations, Global Safety, Novo Nordisk A/S

HENRIK KØHLER SIMONSEN,
PhD, Head of Department, Lif Education, Exhibition & Medicademy

JANIE WILLADSEN
M.Sc. Pharm, QPPV & Head of PV System Compliance Department, LEO Pharma

JANNE MALENE KAMPMANN,
Head of Department, Safety Operations & Surveillance, EU QPPV, GPV Lundbeck, H. Lundbeck A/S

JESPER HALLAS,
Professor, dr. med, University of Southern Denmark

KARSTEN LOLLIKE,
Corporate Vice President, QPPV, Novo Nordisk A/S (Chairman)

LENNART WALDENLIND,
MD, PhD, Clinical Assessor, Signal Detection, Medical Products Agency, Sweden

LENE HOLDRUP,
MSc. Pharm, Senior Director, QPPV, Ferring Pharmaceuticals A/S

PER HARTVIG HONORÉ,
PharmD, PhD, Professor in Pharmacokinetics, Copenhagen University

MINNA KJÆR JØRGENSEN,
M.Sc. Technological & Socio Economic Planning, Program Director Medicademy Pharmacovigilance